comparemela.com

Latest Breaking News On - Georg schett - Page 4 : comparemela.com

CAR T-Cell Approach to Autoimmune Disease Gains Traction

Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

– Initial clinical data from CABA-201 treated patients in Phase 1/2 trials for lupus and/or myositis expected in the first half of 2024, with the .

Miami
Florida
United-states
New-york
Philadelphia
Pennsylvania
Wuxi
Jiangsu
China
University-of-pennsylvania
San-diego
California

CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus

New research at ACR Convergence 2023, the American College of Rheumatology's annual meeting, demonstrates that CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus while maintaining a robust response to vaccines.

United-states
Erlangen
Bayern
Germany
Megan-craig
Georg-schett
American-college-of-rheumatology
University-hospital-erlangen
American-college
Cell
Lupus
Antibodies

CAR-T cell therapy leads to long-term remission in lupus while maintaining vaccine response

CAR-T cell therapy leads to long-term remission in lupus while maintaining vaccine response
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Erlangen
Bayern
Germany
United-states
Georg-schett
American-college-of-rheumatology
University-hospital-erlangen
American-college
Cell-therapy-leads
Long-term-abrogation
While-vaccination-responses-are-maintained
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.